US Stock MarketDetailed Quotes
EXAS Exact Sciences
- 58.850
- +0.060+0.10%
Close Apr 26 16:00 ET
- 58.950
- +0.100+0.17%
Post 18:48 ET
10.82BMarket Cap-52079P/E (TTM)
60.310High58.450Low2.02MVolume59.020Open58.790Pre Close119.46MTurnover1.11%Turnover RatioLossP/E (Static)183.85MShares100.77052wk High3.44P/B10.70BFloat Cap56.05052wk Low--Dividend TTM181.88MShs Float159.540Historical High--Div YieldTTM3.16%Amplitude0.220Historical Low59.165Avg Price1Lot Size
About Exact Sciences Company
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Company Profile
SymbolEXAS
Company NameExact Sciences
Listing DateJan 31, 2001
Issue Price14.00
Founded1995
CEOMr. Kevin T. Conroy
MarketNASDAQ
Employees6600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5505 Endeavor Lane
CityMadison
ProvinceWisconsin
CountryUnited States of America
Zip Code53719
Phone1-608-284-5700
Websitehttp://www.exactsciences.com
Company Executives
- Name
- Position
- Salary
- Kevin T. Conroy
- Chairman of the Board, President and Chief Executive Officer
- 16.12M
- Jeffrey T. Elliott
- Executive Vice President, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
- 4.08M
- Everett V. Cunningham
- Executive Vice President and Chief Commercial Officer
- 4.55M
- Jacob Orville
- Executive Vice President and General Manager, Screening
- 3.67M
- Brian Baranick
- Executive Vice President and General Manager, Precision Oncology
- 3.57M
- Sarah Condella
- Executive Vice President, Human Resources
- --
- Aaron Bloomer
- Executive Vice President, Finance
- --
- James Herriott
- Senior Vice President, General Counsel and Secretary
- --
- Scott D. Coward
- Director
- 1.47M
- Shacey Petrovic
- Independent Director
- 401.25K
- James E. Doyle
- Lead Independent Director
- 442.75K
- Katherine S. Zanotti
- Independent Director
- 406.25K
- Pierre Jacquet
- Independent Director
- 401.25K
- Daniel Joseph Levangie
- Independent Director
- 408.75K
- Dr. Freda C. Lewis-Hall,M.D.
- Independent Director
- 402.75K
- Michael J. Barber
- Independent Director
- --
- Paul J. Clancy
- Independent Director
- 417.75K
- Timothy John Scannell
- Independent Director
- 362.81K
- Kathleen Sebelius
- Independent Director
- 411.75K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
